Evidence map›Paper›PMID 41053020›Full record

ArticleCell death & disease2025

The CHCHD2-CHCHD10 protein complex is modulated by mitochondrial dysfunction and alters lipid homeostasis in the mouse brain.

Jule Gerlach, Paola Pireddu, Xiaoqun Zhang, Simon Wetzel, Mara Mennuni, Dusanka Milenkovic, Hendrik Nolte, Fernanda da Silva Rodrigues, Niclas Branzell, Ibrahim Kaya and 8 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jule Gerlach *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Paola Pireddu *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Xiaoqun ZhangDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Simon WetzelDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1831-0376
Mara MennuniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Dusanka MilenkovicMax Planck Institute for Biology of Ageing, Cologne, Germany.
Hendrik NolteMax Planck Institute for Biology of Ageing, Cologne, Germany.
Fernanda da Silva RodriguesDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Niclas BranzellDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0009-0009-3472-6903
Ibrahim KayaDepartment of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-3345-5602
Rodolfo Garcia VillegasDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Diana Rubalcava-GraciaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
David AlsinaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Regina FeederleCore Facility Monoclonal Antibodies, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-3981-367X
Per E AndrénDepartment of Pharmaceutical Biosciences, Spatial Mass Spectrometry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-4062-7743
Thomas LangerMax Planck Institute for Biology of Ageing, Cologne, Germany.
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Roberta FilogranaDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. roberta.filograna@ki.se.ORCID http://orcid.org/0000-0002-6581-9426

Funding

Vetenskapsrådet (Swedish Research Council) 2022-01477
6 · The paper itself

Abstract

The highly conserved CHCHD2 and CHCHD10 are small mitochondrial proteins residing in the intermembrane space. Recently, mutations in the genes encoding these proteins have been linked to severe disorders, including Parkinson's disease and amyotrophic lateral sclerosis. In cultured cells, a small fraction of CHCHD2 and CHCHD10 oligomerize to form a high molecular weight complex of unknown function. Here, we generated a whole-body Chchd2 knockout mouse to investigate the in vivo role of CHCHD2 and its protein complex. We show that CHCHD2 is crucial for sustaining full motor capacity, normal striatal dopamine levels, and lipid homeostasis in the brain of adult male mice. We also demonstrate that in mouse tissues, CHCHD2 and CHCHD10 exist exclusively as a high molecular weight complex, whose levels are finely tuned under physiological conditions. In response to mitochondrial dysfunction, the abundance and size of the CHCHD2-CHCHD10 complex increase, a mechanism conserved across different tissues. Although the loss of CHCHD2 does not abolish CHCHD10 oligomerization, it enhances cell vulnerability to mitochondrial stress, suggesting that CHCHD2 is protective against mitochondrial damage. Our findings uncover the role of CHCHD2 in preserving tissue homeostasis and provide important insights into the involvement of the CHCHD2-CHCHD10 complex in human diseases.

Indexed as

BrainLipid MetabolismMitochondriaMitochondrial ProteinsTranscription FactorsAnimalsDNA-Binding ProteinsHomeostasisHumansMaleMiceMice, Inbred C57BLMice, KnockoutDNA-Binding ProteinsMitochondrial ProteinsTranscription Factors

Identifiers

PMID41053020
PMCPMC12501252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.